Is a complete NSE/TORNTPHARM research report available?

No complete published report is available for nse/TORNTPHARM (NSE/TORNTPHARM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/TORNTPHARM stock profile: metrics, valuation and analysis

Market cap	1.9T
Revenue (ttm)	157.2B
Net income (ttm)	21.8B
EPS (ttm)	₹62.5
P/E (trailing)	86.7x
P/E (forward)	68.6x
Dividend	₹38.0 (0.77%)
Volume	263,100
Beta	0.14

All NSE/TORNTPHARM indicators

Market & fundamental data

Available fields

225

Groups with data

Currency

INR

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	18,258
Employees Change	1,199%
Employees Change Percent	7.03
Enterprise value	INR 2.1T
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.23
Industry PE Fwd	33.61
Isin	INE685A01028
Last refreshed	2026-09-13
Market cap	INR 1.9T
Price	INR 4,959
Price currency	INR
Rev Per Employee	8,611,419.65x
Sector	Healthcare
Sector PE	47.65
Sector PE Fwd	37.98
Sic	2834
Symbol	nse/TORNTPHARM
Website	https://www.torrentpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.15%
EV Earnings	96.77x
EV/EBIT	57.37x
EV/EBITDA	43.43x
EV/FCF	90.01x
EV/Sales	13.43x
FCF yield	1.24%
Forward P/E	68.63x
P/B ratio	10.76x
P/E ratio	86.75x
P/S ratio	12.04x
PE Ratio10 Y	47.41x
PE Ratio3 Y	58.34x
PE Ratio5 Y	56.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.4%
EBITDA Margin	30.62%
FCF margin	16.78%
Gross margin	75.98%
Gross Profit	INR 119.5B
Gross Profit Growth	33.04%
Gross Profit Growth Q	56.32%
Gross Profit Growth3 Y	18.72%
Gross Profit Growth5 Y	15.22%
Net Income	INR 21.8B
Net Income Growth	8.95%
Net Income Growth Q	3.29%
Net Income Growth Qo Q	45.36%
Net Income Growth Quarters	1%
Net Income Growth Years	4%
Net Income Growth3 Y	19.78%
Net Income Growth5 Y	11.59%
Pretax Margin	18.24%
Profit Margin	13.87%
Profit Per Employee	INR 1.2M
Profitable Quarters	INR 17
Profitable Years	22
Roa5y	9.55
Roe5y	20.5
ROIC	9.15
Roic5y	15.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.99%
Cagr15y	27.98%
Cagr1y	39.32%
Cagr20y	27.92%
Cagr3y	39.68%
Cagr5y	27.64%
Div CAGR10	8.06%
Div CAGR3	19.98%
Div CAGR5	16.77%
EPS Growth	5.67
EPS Growth Q	-8.15
EPS Growth Qo Q	29.07
EPS Growth Quarters	1
EPS Growth Years	4
EPS Growth3 Y	18.55
EPS Growth5 Y	10.9
FCF Growth	18.86%
FCF Growth3 Y	9.34%
FCF Growth5 Y	7.03%
OCF Growth	16.93%
OCF Growth10 Y	0.98%
OCF Growth3 Y	8.48%
OCF Growth5 Y	8.55%
Revenue Growth	32.85x
Revenue Growth Q	54.85x
Revenue Growth Qo Q	17.26x
Revenue Growth Quarters	26x
Revenue Growth Years	9x
Revenue Growth3 Y	16.81x
Revenue Growth5 Y	14.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 23.6B
Debt	INR 150.3B
Debt EBITDA	INR 3.09
Debt Equity	INR 0.85
Debt FCF	INR 6.41
Equity	INR 175.8B
Interest Coverage	5.81
Net Cash	INR -126.7B
Net Cash By Market Cap	INR -6.7
Net Debt EBITDA	INR 2.63
Net Debt Equity	INR 0.72
Net Debt FCF	INR 5.4
Tangible Book Value	INR -200.6B
Tangible Book Value Per Share	INR -593
WACC	4.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.1%
Dividend Growth	18.75%
Dividend Growth Years	2%
Dividend per share	INR 38
Dividend Years	24
Dividend Yield	0.77%
Ex Div Date	2026-05-29
Last Dividend	INR 9
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	572.27%
1Y total return	39.29%
200-day SMA	4,362.4
3Y total return	172.56%
50-day SMA	4,947.9
50-day SMA vs 200-day SMA	50over200
5Y total return	238.78%
All Time High	5,250
All Time High Change	-5.54%
All Time High Date	2026-08-03
All Time Low	9.69
All Time Low Change	51,087.04%
All Time Low Date	2003-04-28
ATR	104.9
Beta	0.14
Ch YTD	28.81
High	4,988
High52	5,250
High52 Date	2026-08-03
High52ch	-5.54%
Low	4,894
Low52	3,480.6
Low52 Date	2025-10-14
Low52ch	42.48%
Ma50ch	0.22%
Price vs 200-day SMA	13.68%
RSI	52.16
RSI Monthly	75.9
RSI Weekly	61.78
Sharpe ratio	1.48x
Sharpe Ratio3y	1.37x
Sharpe Ratio5y	1.03x
Sortino ratio	2.71
Sortino Ratio3y	2.42
Sortino Ratio5y	1.81
Total Return	-2.33%
Tr YTD	29.95
Tr15y	3,949.02%
Tr1m	0.71%
Tr1w	2.1%
Tr3m	11.1%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	146,841,278%
Net Borrowing	118,670,000,000
Shares Insiders	0%
Shares Institutions	17.53%
Shares Qo Q	12.62%
Shares Yo Y	3.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	282,880.05x
Bv Per Share	247.9
CAPEX	INR -6.8B
Ch10y	496.4
Ch15y	3,156.9
Ch1m	0.71
Ch1w	2.1
Ch1y	38.07
Ch20y	10,111.5
Ch3m	11.1
Ch3y	164.8
Ch5y	219.1
Ch6m	12
Change	0.59%
Change From Open	0.61
Close	4,930
Days Gap	-0.02
Depreciation Amortization	11,338,725,000
Dollar Volume	1,304,712,900
Earnings Date	2026-10-27
EBIT	INR 36.8B
EBITDA	INR 48.1B
EPS	INR 62.51
F Score	4
FCF	INR 23.5B
FCF EV Yield	1.11x
Financing CF	101,506,000,000
Fiscal Year End	March
Founded	1,959
Graham Number	769.87857
Graham Upside	-84.48
Income Tax	INR 7.1B
Investing CF	-127,124,100,000
Is Primary Listing	0
Last Earnings Date	2026-07-30
Last Report Date	2026-06-30
Last Split Date	2022-07-08
Last Split Type	Forward
Lynch Fair Value	INR 662
Lynch Upside	-86.64
Ma150	4,527.3
Ma150ch	9.54%
Ma20	4,952.4
Ma20ch	0.13%
Net CF	5,437,200,000
Next Earnings Date	2026-10-27
Open	4,929
P FCF Ratio	80.69
P OCF Ratio	62.6
Payment Date	2026-03-15
Position In Range	69.15
Price Date	2026-09-11
Price EBITDA	INR 39.31
Relative Volume	0.93x
Revenue	157,227,300,000x
Tax By Revenue	4.52x
Tax Rate	24.8%
Tr20y	13,659.65%
Tr6m	12.22%
Volume	263,100

NSE/TORNTPHARM (NSE/TORNTPHARM)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/TORNTPHARM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/TORNTPHARM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/TORNTPHARM

Frequently asked questions